Oscar Health (OSCR) Cash from Investing Activities (2020 - 2025)
Oscar Health's Cash from Investing Activities history spans 6 years, with the latest figure at -$48.7 million for Q4 2025.
- For Q4 2025, Cash from Investing Activities fell 54.88% year-over-year to -$48.7 million; the TTM value through Dec 2025 reached -$241.1 million, up 82.63%, while the annual FY2025 figure was -$241.1 million, 82.63% up from the prior year.
- Cash from Investing Activities reached -$48.7 million in Q4 2025 per OSCR's latest filing, down from $150.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $298.8 million in Q3 2022 to a low of -$708.0 million in Q2 2021.
- Average Cash from Investing Activities over 5 years is -$102.6 million, with a median of -$25.6 million recorded in 2021.
- The largest YoY upside for Cash from Investing Activities was 2516.48% in 2022 against a maximum downside of 3462.43% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$19.8 million in 2021, then tumbled by 3462.43% to -$706.7 million in 2022, then skyrocketed by 124.41% to $172.5 million in 2023, then plummeted by 118.23% to -$31.4 million in 2024, then crashed by 54.88% to -$48.7 million in 2025.
- Per Business Quant, the three most recent readings for OSCR's Cash from Investing Activities are -$48.7 million (Q4 2025), $150.1 million (Q3 2025), and -$168.2 million (Q2 2025).